| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ß3 Displays Cell-, TR Isoform-, and Thyroid Hormone Response Element-Specific ActionsMolecular Endocrinology Group (C.B.H., J.H.D.B., G.R.W.), Division of Medicine and Medical Research Council (MRC) Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London W12 0NN, United Kingdom; Molecular Regulation and Neuroendocrinology Section (P.M., P.M.Y.), Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, and Cancer Biomarkers Research Group (P.M.), Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; and Endocrinology Division (P.M.Y.), Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224
Address all correspondence and requests for reprints to: Graham Williams, Molecular Endocrinology Group, MRC Clinical Sciences Centre, Clinical Research Building 5th Floor, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom. E-mail: graham.williams{at}imperial.ac.uk.
The THRB gene encodes the well-described thyroid hormone (T3) receptor (TR) isoforms TRß1 and TRß2 and two additional variants, TRß3 and TR
ß3, of unknown physiological significance. TRß1, TRß2, and TRß3 are bona fide T3 receptors that bind DNA and T3 and regulate expression of T3-responsive target genes. TR
ß3 retains T3 binding activity but lacks a DNA binding domain and does not activate target gene transcription. TR
ß3 can be translated from a specific TR
ß3 mRNA or is coexpressed with TRß3 from a single transcript that contains an internal TR
ß3 translation start site. In these studies, we provide evidence that the TRß3/
ß3 locus is present in rat but not in other vertebrates, including humans. We compared the activity of TRß3 with other TR isoforms and investigated mechanisms of action of TR
ß3 at specific thyroid hormone response elements (TREs) in two cell types. TRß3 was the most potent isoform, but TR potency was TRE dependent. TR
ß3 acted as a cell-specific and TRE-dependent modulator of TRß3 when coexpressed at low concentrations. At higher concentrations, TR
ß3 was a TRE-selective and cell-specific antagonist of TR
1, -ß1, and -ß3. Both TRß3 and TR
ß3 were expressed in the nucleus in the absence and presence of hormone, and their actions were determined by cell type and TRE structure, whereas TR
ß3 actions were also dependent on the TR isoform with which it interacted. Analysis of these complex responses implicates a range of nuclear corepressors and coactivators as cell-, TR isoform-, and TRE-specific modulators of T3 action.
This article has been cited by other articles:
![]() |
P. J. O'Shea, C. J. Guigon, G. R. Williams, and S.-y. Cheng Regulation of Fibroblast Growth Factor Receptor-1 (Fgfr1) by Thyroid Hormone: Identification of a Thyroid Hormone Response Element in the Murine Fgfr1 Promoter Endocrinology, December 1, 2007; 148(12): 5966 - 5976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |